Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1997 May 1;99(9):2246–2253. doi: 10.1172/JCI119399

Leukocyte adhesion in angiogenic blood vessels. Role of E-selectin, P-selectin, and beta2 integrin in lymphotoxin-mediated leukocyte recruitment in tumor microvessels.

P Borgström 1, G K Hughes 1, P Hansell 1, B A Wolitsky 1, P Sriramarao 1
PMCID: PMC508056  PMID: 9151798

Abstract

Interaction of circulating leukocytes with tumor microvasculature is a critical event in the recruitment of effector cells into the tumor stroma. We have examined the ability of lymphotoxin (TNF-beta), to stimulate rolling, adhesion, and transmigration of leukocytes in angiogenic blood vessels induced by tumor spheroids of Lewis lung carcinoma (LLC) implanted in dorsal skinfold chambers of nude mice. In the absence of cytokine stimulation, circulating leukocytes failed to appreciably interact with tumor microvessels (TMV), although significant rolling and adhesion was observed in normal vessels. However, stimulation with lymphotoxin (LT) resulted in a rapid increase in the number of fast and slow rolling leukocytes in TMV. Treatment with anti-P-selectin mAb 5H1 resulted in inhibition of fast rollers alone, while combination treatment with anti-P-selectin and anti-E-selectin (9A9) mAbs effectively blocked slow rolling of leukocytes. Superfusion of the lymphotoxin-stimulated neovasculature with leukotriene B4 (LTB4) resulted in stable cell adhesion followed by emigration of leukocytes into the tumor stroma. LTB4-mediated adhesion and transmigration was significantly inhibited by treatment with anti-beta2 mAb 2E6. These studies delineate a multistep cascade of leukocyte adhesion in TMV and demonstrate that stimulation of the neovasculature with cytokines and chemoattractants can result in P- and E-selectin-dependent rolling and beta2-dependent stable adhesion followed by transmigration into the tumor stroma.

Full Text

The Full Text of this article is available as a PDF (304.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berger R., Albelda S. M., Berd D., Ioffreda M., Whitaker D., Murphy G. F. Expression of platelet-endothelial cell adhesion molecule-1 (PECAM-1) during melanoma-induced angiogenesis in vivo. J Cutan Pathol. 1993 Oct;20(5):399–406. doi: 10.1111/j.1600-0560.1993.tb00661.x. [DOI] [PubMed] [Google Scholar]
  2. Berlin C., Bargatze R. F., Campbell J. J., von Andrian U. H., Szabo M. C., Hasslen S. R., Nelson R. D., Berg E. L., Erlandsen S. L., Butcher E. C. alpha 4 integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell. 1995 Feb 10;80(3):413–422. doi: 10.1016/0092-8674(95)90491-3. [DOI] [PubMed] [Google Scholar]
  3. Björk J., Hedqvist P., Arfors K. E. Increase in vascular permeability induced by leukotriene B4 and the role of polymorphonuclear leukocytes. Inflammation. 1982 Jun;6(2):189–200. doi: 10.1007/BF00916243. [DOI] [PubMed] [Google Scholar]
  4. Borgström P., Hillan K. J., Sriramarao P., Ferrara N. Complete inhibition of angiogenesis and growth of microtumors by anti-vascular endothelial growth factor neutralizing antibody: novel concepts of angiostatic therapy from intravital videomicroscopy. Cancer Res. 1996 Sep 1;56(17):4032–4039. [PubMed] [Google Scholar]
  5. Butcher E. C. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell. 1991 Dec 20;67(6):1033–1036. doi: 10.1016/0092-8674(91)90279-8. [DOI] [PubMed] [Google Scholar]
  6. Estrov Z., Kurzrock R., Pocsik E., Pathak S., Kantarjian H. M., Zipf T. F., Harris D., Talpaz M., Aggarwal B. B. Lymphotoxin is an autocrine growth factor for Epstein-Barr virus-infected B cell lines. J Exp Med. 1993 Mar 1;177(3):763–774. doi: 10.1084/jem.177.3.763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med. 1995 Jan;1(1):27–31. doi: 10.1038/nm0195-27. [DOI] [PubMed] [Google Scholar]
  8. Fox S. B., Turner G. D., Gatter K. C., Harris A. L. The increased expression of adhesion molecules ICAM-3, E- and P-selectins on breast cancer endothelium. J Pathol. 1995 Dec;177(4):369–376. doi: 10.1002/path.1711770407. [DOI] [PubMed] [Google Scholar]
  9. Fox S. B., Turner G. D., Leek R. D., Whitehouse R. M., Gatter K. C., Harris A. L. The prognostic value of quantitative angiogenesis in breast cancer and role of adhesion molecule expression in tumor endothelium. Breast Cancer Res Treat. 1995;36(2):219–226. doi: 10.1007/BF00666042. [DOI] [PubMed] [Google Scholar]
  10. Fukumura D., Salehi H. A., Witwer B., Tuma R. F., Melder R. J., Jain R. K. Tumor necrosis factor alpha-induced leukocyte adhesion in normal and tumor vessels: effect of tumor type, transplantation site, and host strain. Cancer Res. 1995 Nov 1;55(21):4824–4829. [PubMed] [Google Scholar]
  11. Gamble J. R., Khew-Goodall Y., Vadas M. A. Transforming growth factor-beta inhibits E-selectin expression on human endothelial cells. J Immunol. 1993 May 15;150(10):4494–4503. [PubMed] [Google Scholar]
  12. Gibbons D. L., Rowe M., Cope A. P., Feldmann M., Brennan F. M. Lymphotoxin acts as an autocrine growth factor for Epstein-Barr virus-transformed B cells and differentiated Burkitt lymphoma cell lines. Eur J Immunol. 1994 Aug;24(8):1879–1885. doi: 10.1002/eji.1830240825. [DOI] [PubMed] [Google Scholar]
  13. Hock H., Dorsch M., Kunzendorf U., Qin Z., Diamantstein T., Blankenstein T. Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, or interferon gamma. Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):2774–2778. doi: 10.1073/pnas.90.7.2774. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Jallal B., Powell J., Zachwieja J., Brakebusch C., Germain L., Jacobs J., Iacobelli S., Ullrich A. Suppression of tumor growth in vivo by local and systemic 90K level increase. Cancer Res. 1995 Aug 1;55(15):3223–3227. [PubMed] [Google Scholar]
  15. Kandel J., Bossy-Wetzel E., Radvanyi F., Klagsbrun M., Folkman J., Hanahan D. Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma. Cell. 1991 Sep 20;66(6):1095–1104. doi: 10.1016/0092-8674(91)90033-u. [DOI] [PubMed] [Google Scholar]
  16. Kehrl J. H., Alvarez-Mon M., Delsing G. A., Fauci A. S. Lymphotoxin is an important T cell-derived growth factor for human B cells. Science. 1987 Nov 20;238(4830):1144–1146. doi: 10.1126/science.3500512. [DOI] [PubMed] [Google Scholar]
  17. Kim K. J., Li B., Winer J., Armanini M., Gillett N., Phillips H. S., Ferrara N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature. 1993 Apr 29;362(6423):841–844. doi: 10.1038/362841a0. [DOI] [PubMed] [Google Scholar]
  18. Kunkel E. J., Jung U., Bullard D. C., Norman K. E., Wolitzky B. A., Vestweber D., Beaudet A. L., Ley K. Absence of trauma-induced leukocyte rolling in mice deficient in both P-selectin and intercellular adhesion molecule 1. J Exp Med. 1996 Jan 1;183(1):57–65. doi: 10.1084/jem.183.1.57. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Kuzu I., Bicknell R., Fletcher C. D., Gatter K. C. Expression of adhesion molecules on the endothelium of normal tissue vessels and vascular tumors. Lab Invest. 1993 Sep;69(3):322–328. [PubMed] [Google Scholar]
  20. Labow M. A., Norton C. R., Rumberger J. M., Lombard-Gillooly K. M., Shuster D. J., Hubbard J., Bertko R., Knaack P. A., Terry R. W., Harbison M. L. Characterization of E-selectin-deficient mice: demonstration of overlapping function of the endothelial selectins. Immunity. 1994 Nov;1(8):709–720. doi: 10.1016/1074-7613(94)90041-8. [DOI] [PubMed] [Google Scholar]
  21. Lehr H. A., Leunig M., Menger M. D., Nolte D., Messmer K. Dorsal skinfold chamber technique for intravital microscopy in nude mice. Am J Pathol. 1993 Oct;143(4):1055–1062. [PMC free article] [PubMed] [Google Scholar]
  22. Metlay J. P., Witmer-Pack M. D., Agger R., Crowley M. T., Lawless D., Steinman R. M. The distinct leukocyte integrins of mouse spleen dendritic cells as identified with new hamster monoclonal antibodies. J Exp Med. 1990 May 1;171(5):1753–1771. doi: 10.1084/jem.171.5.1753. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Miyake K., Medina K., Ishihara K., Kimoto M., Auerbach R., Kincade P. W. A VCAM-like adhesion molecule on murine bone marrow stromal cells mediates binding of lymphocyte precursors in culture. J Cell Biol. 1991 Aug;114(3):557–565. doi: 10.1083/jcb.114.3.557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Modzelewski R. A., Davies P., Watkins S. C., Auerbach R., Chang M. J., Johnson C. S. Isolation and identification of fresh tumor-derived endothelial cells from a murine RIF-1 fibrosarcoma. Cancer Res. 1994 Jan 15;54(2):336–339. [PubMed] [Google Scholar]
  25. Nolte D., Schmid P., Jäger U., Botzlar A., Roesken F., Hecht R., Uhl E., Messmer K., Vestweber D. Leukocyte rolling in venules of striated muscle and skin is mediated by P-selectin, not by L-selectin. Am J Physiol. 1994 Oct;267(4 Pt 2):H1637–H1642. doi: 10.1152/ajpheart.1994.267.4.H1637. [DOI] [PubMed] [Google Scholar]
  26. Norton C. R., Rumberger J. M., Burns D. K., Wolitzky B. A. Characterization of murine E-selectin expression in vitro using novel anti-mouse E-selectin monoclonal antibodies. Biochem Biophys Res Commun. 1993 Aug 31;195(1):250–258. doi: 10.1006/bbrc.1993.2037. [DOI] [PubMed] [Google Scholar]
  27. Onrust S. V., Hartl P. M., Rosen S. D., Hanahan D. Modulation of L-selectin ligand expression during an immune response accompanying tumorigenesis in transgenic mice. J Clin Invest. 1996 Jan 1;97(1):54–64. doi: 10.1172/JCI118406. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Piali L., Fichtel A., Terpe H. J., Imhof B. A., Gisler R. H. Endothelial vascular cell adhesion molecule 1 expression is suppressed by melanoma and carcinoma. J Exp Med. 1995 Feb 1;181(2):811–816. doi: 10.1084/jem.181.2.811. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Picarella D. E., Kratz A., Li C. B., Ruddle N. H., Flavell R. A. Transgenic tumor necrosis factor (TNF)-alpha production in pancreatic islets leads to insulitis, not diabetes. Distinct patterns of inflammation in TNF-alpha and TNF-beta transgenic mice. J Immunol. 1993 May 1;150(9):4136–4150. [PubMed] [Google Scholar]
  30. Pober J. S. Effects of tumour necrosis factor and related cytokines on vascular endothelial cells. Ciba Found Symp. 1987;131:170–184. doi: 10.1002/9780470513521.ch12. [DOI] [PubMed] [Google Scholar]
  31. Qin Z., Blankenstein T. Tumor growth inhibition mediated by lymphotoxin: evidence of B lymphocyte involvement in the antitumor response. Cancer Res. 1995 Nov 1;55(21):4747–4751. [PubMed] [Google Scholar]
  32. Qin Z., van Tits L. J., Buurman W. A., Blankenstein T. Human lymphotoxin has at least equal antitumor activity in comparison to human tumor necrosis factor but is less toxic in mice. Blood. 1995 May 15;85(10):2779–2785. [PubMed] [Google Scholar]
  33. Springer T. A. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 1994 Jan 28;76(2):301–314. doi: 10.1016/0092-8674(94)90337-9. [DOI] [PubMed] [Google Scholar]
  34. Sriramarao P., Anderson W., Wolitzky B. A., Broide D. H. Mouse bone marrow-derived mast cells roll on P-selectin under conditions of flow in vivo. Lab Invest. 1996 Mar;74(3):634–643. [PubMed] [Google Scholar]
  35. Sriramarao P., von Andrian U. H., Butcher E. C., Bourdon M. A., Broide D. H. L-selectin and very late antigen-4 integrin promote eosinophil rolling at physiological shear rates in vivo. J Immunol. 1994 Nov 1;153(9):4238–4246. [PubMed] [Google Scholar]
  36. Strieter R. M., Polverini P. J., Arenberg D. A., Kunkel S. L. The role of CXC chemokines as regulators of angiogenesis. Shock. 1995 Sep;4(3):155–160. doi: 10.1097/00024382-199509000-00001. [DOI] [PubMed] [Google Scholar]
  37. Torres Filho I. P., Hartley-Asp B., Borgström P. Quantitative angiogenesis in a syngeneic tumor spheroid model. Microvasc Res. 1995 Mar;49(2):212–226. doi: 10.1006/mvre.1995.1017. [DOI] [PubMed] [Google Scholar]
  38. Von Andrian U. H., Hansell P., Chambers J. D., Berger E. M., Torres Filho I., Butcher E. C., Arfors K. E. L-selectin function is required for beta 2-integrin-mediated neutrophil adhesion at physiological shear rates in vivo. Am J Physiol. 1992 Oct;263(4 Pt 2):H1034–H1044. doi: 10.1152/ajpheart.1992.263.4.H1034. [DOI] [PubMed] [Google Scholar]
  39. Wu N. Z., Klitzman B., Dodge R., Dewhirst M. W. Diminished leukocyte-endothelium interaction in tumor microvessels. Cancer Res. 1992 Aug 1;52(15):4265–4268. [PubMed] [Google Scholar]
  40. Zocchi M. R., Poggi A. Lymphocyte-endothelial cell adhesion molecules at the primary tumor site in human lung and renal cell carcinomas. J Natl Cancer Inst. 1993 Feb 3;85(3):246–247. doi: 10.1093/jnci/85.3.246. [DOI] [PubMed] [Google Scholar]
  41. von Andrian U. H., Chambers J. D., McEvoy L. M., Bargatze R. F., Arfors K. E., Butcher E. C. Two-step model of leukocyte-endothelial cell interaction in inflammation: distinct roles for LECAM-1 and the leukocyte beta 2 integrins in vivo. Proc Natl Acad Sci U S A. 1991 Sep 1;88(17):7538–7542. doi: 10.1073/pnas.88.17.7538. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES